Великолепный мозг в любом возрасте

Behnke, К., G. S. Jensen, Н. J. Graubaum, et al. 2002. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Advances in Therapy 19(1): 43–52.

Brenner, R., V. Azbel, S. Madhusoodanan, et al. 2000. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A doubleblind, randomized pilot study. Clinical Therapeutics 22(4): 411–419.

Kalb, R., R. D. Trautmann- Sponsel, and M. Kieser. 2001. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double- blind multicenter clinical trial. Pharmacopsychiatry 34(3): 96-103.

Simeon, J., M. Nixon, R. Milin, et al. 2005. Open- label pilot study of St. Johns wort in adolescent depression. Journal of Child & Adolescent Psychopharmacology 15(2): 293–301.

Теанин

Bryan, J. 2008. Psychological effects of dietary components of tea: caffeine and Ltheanine. Nutrition Review 66(2): 82–90.

Dimpfel, W., A. Kler, E. Kriesl, et al. 2007. Source density analysis of the human EEG after ingestion of a drink containing decaffeinated extract of green tea enriched with L- theanine and theogallin. Nutritional Neuroscience 10(3–4): 169–180.

Nobre, A. C., A. Rao, and G. N. Owen. 2008. L- theanine, a natural constituent in tea, and its effect on mental state. Asia Pacific Journal of Clinical Nutrition 17(Suppl. 1): 167–168.

Rogers, P. J., J. E. Smith, S. V: Heatherley, et al. 2008. Time for tea: Mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology 195(4): 569–577.

Цинк

Arnold, L. Е., Н. Bozzolo, J. Hollway, et al. 2005. Serum zinc correlates with parent- and teacher- rated inattention in children with attention- deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology 15(4): 628–636.

Bilici, M., F. Yildirim, S. Kandil, et al. 2004. Double- blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 28(1): 181–190.

Yorbik, O., M. F. Ozdag, A. Olgun, et al. 2008. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 32(3): 662–667.

Глава 7

Amen, D. G., and L. C. Routh. 2003. Healing Anxiety and Depression. New York: Putnam.

Антидепрессивный эффект физических упражнений

Babyak, M., J. A. Blumenthal, S. Herman, et al. 2000. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine 62(5): 633–638.

Blumenthal, J. A., M. A. Babyak, P. M. Doraiswamy, et al. 2007. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosomatic Medicine 69(7): 587–596.

Kessler, R. С., P. A. Berglund, O. Dernier, et al. 2005. Lifetime prevalence and ageof-onset distributions of DSM- IV disorders in the National Comorbidity Survey Replication (NCS- R). Archives of General Psychiatry 62(6): 593–602.

ГАМК

Abdou, А. М., S. Higashiguchi, К. Horie, et al. 2006. Relaxation and immunity enhancement effects of gamma- aminobutyric acid (GABA) administration in humans. Biofactors 26(3): 201–208.

Cocito, L., A. Bianchetti, L. Bossi, et al. 1994. GABA 30 and phosphati-dylserine in human photosensitivity: A pilot study. Epilepsy Research 17: 49–53.

Green, M. L., R. G. Green, and W. Santoro. 1988. Daily relaxation modifies serum and salivary immunoglobulins and psychophysi-ologic symptom severity. Biofeedback &. Self Regulation 13: 187–199.

Loeb, С., E. Benassi, G. P. Bo, et al. 1987. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Research 1: 209–212.

Гипербарическая оксигенация

Hopkins, R. О., L. К. Weaver, К. J. Valentine, et al. 2007. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. American Journal of Respiratory and Critical Care Medicine 176(10): 1001–1006.

Lo, C. P., S. Y. Chen, M. C. Chou. 2007. Diffusion- tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. European Journal of Neurology 14(7): 777–782.

Инозитол

Barak, Y., J. Levine, A. Glasman, et al. 1996. Inositol treatment of Alzheimer’s disease: a double-blind, cross- over placebo controlled trial. Progress in europsychopharmacology and Biological Psychiatry 20(4): 729–735.

Carey, Р. D., J. Warwick, В. Н. Harvey, et al. 2004. Single photon emission computed tomography (SPECT) in obsessive- compulsive disorder before and after treatment with inositol. Metabolic Brain Disease 19(1–2): 125–134.

Chengappa, K. N., J. Levine, S. Gershon, et al. 2000. Inositol as an addon treatment for bipolar depression. Bipolar Disorders 2(1): 47–55.

Fux, M., J. Levine, A. Aviv, et al. 1996. Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry 153(9): 1219–1221.

Кава-кава

Attele, A. S., J. T. Xie, C. S. Yuan. 2000. Treatment of insomnia: an alternative approach. Alternative Medicine Review 5(3): 249–259.

Basch, E., C. Ulbricht, P. Hammerness, et al. 2002. Kava monograph. Journal of Herbal Pharmacotherapy 2(4): 65–91.

Boerner, R. J., and S. Klement. 2004. Attenuation of neuroleptic- induced extrapyramidal side effects by Kava special extract WS 1490. Wiener Medizin i — sche Wochenschrift 154(21–22): 508–510.